Electrical impedance spectroscopy (EIS) has been recognized to characterize oxidized low-density lipoprotein (oxLDL) in the metabolically active plaque. However, intravascular deployment of 3-D EIS-derived electrical impedance tomography (EIT) for endoluminal mapping of oxLDL-laden arterial walls remains an unmet clinical challenge. To this end, we designed the 6-point microelectrode arrays that were circumferentially configurated onto the balloon catheter for 15 intravascular EIS permutations. In parallel, we created the metabolically active plaques by performing partial ligation of right carotid artery in Yorkshire mini-pigs (n = 6 males), followed by demonstrating the plaque progression at baseline, 8 weeks, and 16 weeks of high-fat diet via computed tomography (CT) angiogram. Next, we deployed the 3-D EIS sensors to the right and left carotid arteries, and we demonstrated 3-D EIS mapping of metabolically active endolumen in the right but not left carotid arteries as evidenced by the positive E06 immunostaining for oxLDL-laden regions. By considering electrical conductivity (σ) and permittivity (ε) properties of collagen, lipid, and smooth muscle presence in the arterial wall, we further validated the 3-D EIS-derived EIT by reconstructing the histology of right and left carotid arteries for the finite element modeling of the oxLDL-laden endolumen, and we accurately predicted 3-D EIS mapping. Thus, we establish the capability of 3-D EIS-derived EIT to detect oxLDL-laden arterial walls with translational implication to predict metabolically active plaques prone to acute coronary syndromes or stroke.

We have developed an efficient, streamlined, cost-effective approach to obtain Investigational New Drug (IND) approvals from the Food and Drug Administration (FDA) for positron emission tomography (PET) imaging probes (while the FDA uses the terminology PET drugs, we are using “PET imaging probes,” “PET probes,” or “probes” as the descriptive terms). The required application and supporting data for the INDs were collected in a collaborative effort involving appropriate scientific disciplines. This path to INDs was successfully used to translate three [18 F]fluoro-arabinofuranosylcytosine (FAC) analog PET probes to phase 1 clinical trials. In doing this, a mechanism has been established to fulfill the FDA regulatory requirements for translating promising PET imaging probes from preclinical research into human clinical trials in an efficient and cost-effective manner.Electronic supplementary materialThe online version of this article (doi:10.1007/s11307-014-0735-2) contains supplementary material, which is available to authorized users.

The squamates (lizards and snakes) are close relatives of birds and mammals, with more than 10,000 described species that display extensive variation in a number of important biological traits, including coloration, venom production, and regeneration. Due to a lack of genomic tools, few genetic studies in squamates have been carried out. The leopard gecko, Eublepharis macularius, is a popular companion animal, and displays a variety of coloration patterns. We took advantage of a large breeding colony and used linkage analysis, synteny, and homozygosity mapping to investigate a spontaneous semi-dominant mutation, “Lemon Frost”, that produces white coloration and causes skin tumors (iridophoroma). We localized the mutation to a single locus which contains a strong candidate gene, SPINT1, a tumor suppressor implicated in human skin cutaneous melanoma (SKCM) and over-proliferation of epithelial cells in mice and zebrafish. Our work establishes the leopard gecko as a tractable genetic system and suggests that a tumor suppressor in melanocytes in humans can also suppress tumor development in iridophores in lizards.

RESUMENLas micotoxinas constituyen un problema en el ámbito mundial por su alta incidencia y niveles de ocurrencia en los alimentos para humanos y animales. Las condiciones de colonización de los sustratos por hongos micotoxigénicos así como su posterior contaminación con micotoxinas juegan un papel fundamental en las estrategias de vigilancia y control. Entre los principales hongos micotoxigénicos se encuentran los géneros Aspergillus spp., Penicillium spp. y Fusarium spp. Dentro de las familias más importantes de micotoxinas se encuentran: las aflatoxinas, los tricoticenos, la ocratoxina A, las fumonisinas y la zearalenona. Los diferentes mecanismos de acción tóxica de estas micotoxinas constituyen un riesgo para la salud humana y animal constituyéndose en una problemática de salud pública. En Colombia la situación es compleja dada la deficiente investigación al respecto, los estudios realizados en el país han demostrado que la contaminación de alimentos por algunas micotoxinas es significativa y que se deben formular políticas sanitarias para afrontar este limitante. Se discute el riesgo potencial de las micotoxinas para la salud pública, las dificultades en el diagnóstico y la legislación así como las implicaciones en la seguridad e inocuidad alimentaria.Palabras Clave: Micotoxinas, salud pública, abastecimiento de alimentos, medicina veterinaria (fuente: DeCS, BIREME). ABSTRACT Micotoxins in Public HealthMycotoxins have become a worldwide problem due to their high incidence and levels of occurrence in human food and animal feed. The conditions for colonising substrates by mycotoxigenic fungus and later contamination by mycotoxins play an important role in surveillance and control strategies. The main mycotoxigenic funguses are the Aspergillus spp., Penicillium spp. and 129

No abstract